Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Neurocrine Biosciences Inc (NBIX) vs Union Pacific Corporation (UNP) Price & Performance

Neurocrine Biosciences IncTrade
Union Pacific CorporationTrade

Price performance (Past 24H)

Key statistics

Neurocrine Biosciences Inc vs Union Pacific Corporation — how do they compare? Neurocrine Biosciences Inc trades at $179.88 (market cap $17.40B), while Union Pacific Corporation trades at $295.5 (market cap $175.89B). The key difference: Union Pacific Corporation is far larger — about 10.1× Neurocrine Biosciences Inc's market cap, and Union Pacific Corporation pays a 1.86% dividend while Neurocrine Biosciences Inc pays none. Which is the better fit depends on your goals.

NBIXUNP
Market Cap
$17.40B$175.89B
Sector
HealthIndustrials
52-Week High
$180.55$301.75
52-Week Low
$123.10$214.91
Enterprise Value
$16.49B$206.36B
Dividend Yield
1.86%

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Neurocrine Biosciences Inc

Neurocrine Biosciences, Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing innovative treatments for neurological, endocrine, and psychiatric disorders. The company's portfolio targets conditions such as tardive dyskinesia, endometriosis, and Parkinson's disease. NBIX leverages its expertise in neurobiology and small-molecule drug development to address diseases with significant unmet medical needs.

Read more on NBIX

About Union Pacific Corporation

Omaha, Nebraska-based Union Pacific is the largest public railroad in North America. Operating on more than 30,000 miles of track in the western two thirds of the U.S., UP generated roughly $22 billion of revenue in 2021 by hauling coal, industrial products, intermodal containers, agriculture goods, chemicals, and automotive goods. UP owns about one fourth of Mexican railroad Ferromex and derives about 10% of its revenue hauling freight to and from Mexico.

Read more on UNP